Cutaneous adverse reactions associated with combination elvitegravir/cobicistat/emtricitabine/tenofovir tablets in patients with HIV - 09/05/15
Finola M. Bruins, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Oyetewa B. Oyerinde, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Alba Posligua, MD, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Dennis P. West, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Beatrice Nardone, MD, PhD, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Monica Rani, MD, Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 72 - N° 5S1
P. AB207 - mai 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?